XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income including non-controlling interests $ 296,999 $ 468,314
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 133,791 44,673
Gain on sale of assets (1,227) (520,421)
Impairment 23,304 0
Deferred income taxes 73,923 (7)
Net (gain) loss on derivative instruments (66,934) 367,922
Net (gain) loss from investment in unconsolidated affiliate 2,216 (60,137)
Equity-based compensation expenses 11,854 4,848
Deferred financing costs amortization and other (3,791) 3,433
Working capital and other changes:    
Change in accounts receivable, net (14,657) (111,813)
Change in inventory (12,753) 667
Change in prepaid expenses 1,211 (369)
Change in accounts payable, interest payable and accrued liabilities 8,176 52,122
Change in other assets and liabilities, net 16,699 16,348
Net cash provided by operating activities 468,811 265,580
Cash flows from investing activities:    
Capital expenditures (172,328) (48,831)
Proceeds from divestitures, net of cash divested 7,034 147,056
Costs related to divestitures 0 (11,368)
Derivative settlements (91,656) (70,670)
Proceeds from sale of investment in unconsolidated affiliate 12,347 0
Distributions from investment in unconsolidated affiliate 3,015 13,116
Net cash provided by (used in) investing activities (241,588) 29,303
Cash flows from financing activities:    
Proceeds from revolving credit facilities 0 15,000
Deferred financing costs 0 (9)
Repurchases of common stock (15,003) 0
Tax withholding on vesting of equity-based awards (10,300) (4,132)
Dividends paid (202,473) (70,579)
Payments on finance lease liabilities (388) (229)
Proceeds from warrants exercised 90 457
Net cash used in financing activities (228,074) (59,492)
Increase (decrease) in cash and cash equivalents (851) 235,391
Cash and cash equivalents:    
Beginning of period 593,151 174,783
End of period 592,300 410,174
Supplemental non-cash transactions:    
Change in accrued capital expenditures 46,097 17,504
Change in asset retirement obligations 234 (428)
Investment in unconsolidated affiliate $ 0 $ 568,312